RecruitingNCT04934540
The Global En Bloc Resection of Bladder Tumour Registry
Sponsor
Chinese University of Hong Kong
Enrollment
2,000 participants
Start Date
Jan 1, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The study aims to collect data on ERBT globally in order to clarify its role in the management of bladder cancer over a 5-year observation period.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Adult patients \>=18 years old with informed consent
- Presence of bladder tumour undergoing transurethral ERBT
Exclusion Criteria3
- Presence or previous history of upper tract urothelial carcinoma
- Presence of other active malignancy
- Pregnancy
Interventions
PROCEDUREEn bloc resection of bladder tumour
En bloc resection of bladder tumour (ERBT) is a novel surgical technique in which the bladder tumour is resected in one piece
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04934540
Related Trials
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCT000268841 location
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
NCT0712999379 locations
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
NCT0697316127 locations
Bio Clinical Collection of Urothelial Carcinoma
NCT049704721 location
Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
NCT074754031 location